Recursion Pharmaceuticals said on Tuesday it will lay off around 20% of its workforce and focus on developing drugs for rare diseases and cancers to reduce cash burn during a prolonged biotech ...

JavaScript tools and frameworks thrive and evolve in an ecosystem that is equal parts competitive and collaborative. This ...

Based on its latest expense profile and business plan, after cutting its staff, Recursion said it now expects its projected cash runway to extend into the fourth quarter of 2027. Recursion will pay ...

How has JavaScript and web development changed in 2023? Learn about the top 10 updates to Next.js, React, Angular, Vue, and Node.js.

JavaScript is the the programming language that built the web. Learn how it evolved into a powerful tool for building websites, servers with Node.js, mobile apps, desktop software, and more.

In a roughly 75-25 deal, Recursion Bio and Exscientia will (if the merger goes through) become one company, combining Recursion’s expertise in biology with Exscientia’s focus on chemistry.

In one of the biggest M&A deals involving artificial intelligence-focused drug developers to date, Recursion Pharma has agreed to join with Exscientia in an all-stock transaction valued at $688 ...

Learn how to invest in stocks, including how to select a brokerage account and research stock market investments. Many, or all, of the products featured on this page are from our advertising ...